ArticleInflammatory intestinal diseases

Short- and Long-Term Effectiveness and Safety of Vedolizumab in Crohn's Disease: A Multicenter Retrospective Study from the Hokkaido Phoenix Cohort.

Shinsuke Otagiri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.